Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kela is a Belgian pharmaceutical company founded in 1941, specializing in the development, manufacturing, and commercialization of both human and veterinary medicines. The company operates a significant manufacturing facility in Hoogstraten, Belgium, producing a wide range of products including antibiotics, vitamins, and specialized treatments like folic acid for prenatal care. Kela Pharma, its human health division, focuses on niche therapeutic areas and high-quality generic formulations distributed globally. The company also provides contract manufacturing services (CMO) to other pharmaceutical entities, leveraging its GMP-certified facilities. With a presence in over 100 countries, Kela maintains a strong international footprint, particularly in Europe, Africa, and Asia. The firm remains a family-owned enterprise, emphasizing long-term stability and quality in its production processes.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on KELA Pharma.